VISTAGEN THERAPEUTICS, INC. Increase (Decrease) in Deferred Revenue
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Increase (Decrease) in Deferred Revenue of -$320.80 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2021-08-12
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2021-06-30 was -$320.80K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2020-06-30 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2020-03-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2019-12-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2021 was $3.67M.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2020 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2013 was -$13.20K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2012 was -$65.60K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 157 month | Increase (Decrease) in Deferred Revenue 160 month | Increase (Decrease) in Deferred Revenue 163 month | Increase (Decrease) in Deferred Revenue 166 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$320.80K 10-Q · filed 2021-08-12 | ||||||||||
| 2021-03-31 | $3.67M 10-K · filed 2021-06-29 | ||||||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 2 quarters · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2021-08-12 | $0.00 derived: sum of 4 quarters · filed 2021-08-12 | |||||||
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | $0.00 derived: sum of 2 quarters · filed 2021-06-29 | $0.00 derived: sum of 3 quarters · filed 2021-06-29 | $0.00 10-K · filed 2021-06-29 | |||||||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 10-Q · filed 2020-02-13 | ||||||||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |||||||||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-13 | ||||||||||
| 2018-12-31 | -$18.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $122.80K derived: sum of 2 quarters · filed 2020-02-13 | $109.20K 10-Q · filed 2020-02-13 | ||||||||
| 2018-09-30 | $141.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $128.00K 10-Q · filed 2019-11-07 | |||||||||
| 2018-06-30 | -$13.60K 10-Q · filed 2019-08-13 | ||||||||||
| 2017-12-31 | $159.90K 10-Q · filed 2019-02-12 | ||||||||||
| 2013-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $0.00 derived: sum of 2 quarters · filed 2014-06-25 | $0.00 derived: sum of 3 quarters · filed 2014-06-25 | -$13.20K 10-K · filed 2014-06-25 | |||||||
| 2012-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | -$13.20K 10-Q · filed 2014-02-14 | -$33.10K derived: sum of 4 quarters · filed 2014-02-14 | |||||||
| 2012-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-14 | -$13.20K 10-Q · filed 2013-11-14 | -$33.10K derived: sum of 3 quarters · filed 2013-11-14 | -$13.20K derived: sum of 4 quarters · filed 2013-11-14 | |||||||
| 2012-06-30 | -$13.20K 10-Q · filed 2013-08-14 | -$33.10K derived: sum of 2 quarters · filed 2013-08-14 | -$13.20K derived: sum of 3 quarters · filed 2013-08-14 | -$39.40K derived: sum of 4 quarters · filed 2013-08-14 | |||||||
| 2012-03-31 | -$19.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-18 | $0.00 derived: sum of 2 quarters · filed 2013-07-18 | -$26.20K derived: sum of 3 quarters · filed 2013-07-18 | -$65.60K 10-K · filed 2013-07-18 | $13.20K 10-K · filed 2012-07-02 | ||||||
| 2011-12-31 | $19.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | -$6.30K derived: sum of 2 quarters · filed 2013-02-14 | -$45.70K 10-Q · filed 2013-02-14 | -$45.74K 10-Q · filed 2012-02-14 | -$69.03K derived: sum of 4 quarters · filed 2013-02-14 | $33.03K 10-Q · filed 2012-02-14 | |||||
| 2011-09-30 | -$26.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-14 | -$65.60K 10-Q · filed 2012-11-14 | -$65.56K 10-Q · filed 2011-11-14 | -$88.93K derived: sum of 3 quarters · filed 2012-11-14 | -$195.75K derived: sum of 4 quarters · filed 2012-11-14 | $13.21K 10-Q · filed 2011-11-14 | |||||
| 2011-06-30 | -$39.40K 10-Q · filed 2012-08-14 | -$39.39K 10-Q · filed 2011-08-22 | -$62.73K derived: sum of 2 quarters · filed 2012-08-14 | -$169.55K derived: sum of 3 quarters · filed 2012-08-14 | -$134.72K derived: sum of 4 quarters · filed 2012-08-14 | $39.39K 10-Q · filed 2011-08-22 | |||||
| 2011-03-31 | -$23.33K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02 | -$130.15K derived: sum of 2 quarters · filed 2012-07-02 | -$95.33K derived: sum of 3 quarters · filed 2012-07-02 | -$60.50K 10-K · filed 2012-07-02 | |||||||
| 2010-12-31 | -$106.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | -$71.99K derived: sum of 2 quarters · filed 2012-02-14 | -$37.17K 10-Q · filed 2012-02-14 | ||||||||
| 2010-09-30 | $34.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | $69.65K 10-Q · filed 2011-11-14 | |||||||||
| 2010-06-30 | $34.83K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |